Denovo Biopharma - About the company
Denovo Biopharma is a series D company based in San Diego (United States), founded in 2013 by . It operates as a Developer of genomic biomarker discovery platform. Denovo Biopharma has raised $172M in funding from investors like CICC, and Qcc. The company has 2113 active competitors, including 513 funded and 367 that have exited. Its top competitors include companies like Avidity Biosciences, Univercells and Metabolon.
Company Details
Developer of genomic biomarker discovery platform. The company provides a novel biomarker solution to personalize drug development with many therapeutic areas, such as oncology, metabolic, cardiology, immunology, and neurology.
- Website
- Email ID
- @denovobiopharma.com
Key Metrics
Founded Year
2013
Location
San Diego, United States
Stage
Series D
Total Funding
in 4 rounds
Latest Funding Round
Investors
Ranked
34th among 2113 active competitors
Employee Count
as on Dec 31, 2022
Similar Companies
Legal entities associated with Denovo Biopharma
Denovo Biopharma is associated with 1 legal entity given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Dec 31, 2012 | - | 813 | 813 |
Get your free copy of Denovo Biopharma's company profile
Denovo Biopharma's funding and investors
Denovo Biopharma has raised a total funding of $172M over 4 rounds. Its first funding round was on Jul 2015. Its latest funding round was a Series D round on Dec 08, 2020 for $45.9M. 1 investor participated in its latest round, which include Goldstone Investment , CITIC Securities, Yingke Capital and Sangel Capital.
Here is the list of recent funding rounds of Denovo Biopharma:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Dec 08, 2020 | $45.9M | Series D | 7458551 | 5790895 | |
Jun 28, 2020 | $83.3M | Series C | 3235796 | 4975455 | Share Capital, Jiuyou Capital, and |
Oct 31, 2019 | $42.6M | Series B | 6511730 | 2531019 | , Share Capital, and |
Access funding benchmarks and valuations. Sign up today!View details of Denovo Biopharma's funding rounds and investors
Denovo Biopharma's founders and board of directors
The founders of Denovo Biopharma is . is the CEO of Denovo Biopharma.
View details of Denovo Biopharma's Founder profiles and Board Members
Denovo Biopharma's employee count trend
Denovo Biopharma has 42 employees as of Dec 22. The total employee count is 55.6% more than what it was in Dec 21. Here is Denovo Biopharma's employee count trend over the years:
Uncover Denovo Biopharma's growth story! Sign up today!Denovo Biopharma's Competitors and alternates
Top competitors of Denovo Biopharma include Avidity Biosciences, Univercells and Metabolon. Here is the list of Top 10 competitors of Denovo Biopharma, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st |  Avidity Biosciences 2012, San Diego (United States), Public | Develops antibody-siRNA complexes to treat cancer | $143M | Eight Roads Ventures, AlexandriaÌý&²¹³¾±è;Ìý | 67/100 |
2nd | Univercells 2013, Charleroi (Belgium), Series D | Provider of biomanufacturing technology services for biopharma sector | $151M | Sambrinvest, HTHÌý&²¹³¾±è;Ìý | 67/100 |
3rd | Metabolon 2000, Morrisville (United States), Series H | Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine | $181M | , Fulcrum Financial GroupÌý&²¹³¾±è;Ìý | 67/100 |
4th | Sutro Biopharma 2003, San Francisco (United States), Public | Developer of antibody-based therapeutics for cancer therapy | $175M | Lilly Ventures, Eventide AudioÌý&²¹³¾±è;Ìý | 67/100 |
5th |  Alector 2013, San Francisco (United States), Public | Developing immuno-modulatory therapies for dementia and other neurodegenerative disorders | $215M | Foresite Capital, Dementia Discovery FundÌý&²¹³¾±è;Ìý | 65/100 |
6th | _1530865304957.jpg?height=40&width=40){kind=logo} Judges Scientific 2002, London (United Kingdom), Public | Acquisition and development of scientific instrument businesses | - | 64/100 | |
7th | Maze Therapeutics 2018, Redwood City (United States), Public | Developer of genetic bio-markers in neurological, metabolic, and renal diseases | $496M | Foresite Capital, Timefolio CapitalÌý&²¹³¾±è;Ìý | 64/100 |
8th |  Straumann Group 1954, Basel (Switzerland), Public | A portfolio of dental products | - | 64/100 | |
9th |  Vividion Therapeutics 2016, Oceanside (United States), Acquired | Developing novel drugs based on a proteome-wide ligand and target discovery platform | $271M | Versant Ventures, Arch Venture PartnersÌý&²¹³¾±è;Ìý | 63/100 |
10th | Savara Pharma 2008, Austin (United States), Public | Developer of therapeutics for rare respiratory diseases | $67.8M | , Keiretsu CapitalÌý&²¹³¾±è;Ìý | 63/100 |
34th | 2013, San Diego (United States), Series D | Developer of genomic biomarker discovery platform | $172M | Goldstone Investment , CITIC SecuritiesÌý&²¹³¾±è;Ìý | 56/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Denovo Biopharma's competitors? Click to see the top ones
Denovo Biopharma's Investments and acquisitions
Denovo Biopharma has made no investments or acquisitions yet.
Reports related to Denovo Biopharma
Here is the latest report on Denovo Biopharma's sector:
View
News related to Denovo Biopharma
Media has covered Denovo Biopharma for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
PR Newswire•Oct 09, 2024•Denovo Biopharma
•
•
PR Newswire•Jul 28, 2022•Denovo Biopharma
•
•
PR Newswire•Feb 01, 2022•Denovo Biopharma
•
•
•
•
PR Newswire•Jul 17, 2020•Denovo Biopharma
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Denovo Biopharma
When was Denovo Biopharma founded?
Denovo Biopharma was founded in 2013.Where is Denovo Biopharma located?
Denovo Biopharma is located in San Diego, United States.Is Denovo Biopharma a funded company?
Denovo Biopharma is a funded company, its first funding round was on Jul 2015.When was the latest funding round of Denovo Biopharma?
Denovo Biopharma's latest funding round was on Dec 08, 2020.What is the annual revenue of Denovo Biopharma?
Annual revenue of Denovo Biopharma is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Bars Over Bottles - United States based, 2019 founded, Unfunded company
- Daniel Heltemes - Munich based, 2018 founded, Unfunded company
- SISMA - Scandicci based, 2015 founded, Funding Raised company
- Solo Pictures - Fort Lauderdale based, Seed company
- JTRS - Cheshire based, 2006 founded, Acquired company
- SKG Travel - Mumbai based, 2023 founded, Unfunded company
